Skip to main content
Erschienen in: Journal of Neurology 11/2019

03.07.2019 | Original Communication

Selection of anterior circulation acute stroke patients for mechanical thrombectomy

verfasst von: Fabrizio Sallustio, Nicola Toschi, Alfredo Paolo Mascolo, Federico Marrama, Daniele Morosetti, Valerio Da Ros, Roberto Gandini, Fana Alemseged, Giacomo Koch, Marina Diomedi

Erschienen in: Journal of Neurology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The use of mechanical thrombectomy (MT) for acute ischemic stroke (AIS) patients has increased with a parallel burden in procedural costs. We tested whether a new prognostic score could identify patients who are unlikely to benefit from MT.

Methods

Patients from our endovascular stroke registry were assessed for imaging and clinical outcome measures and randomly divided into two subsets for derivation and validation. We created a new prognostic score based on clinical and radiological prognostic factors of poor outcome (mRS score ≥ 3) from the derivation cohort. Receiver operating characteristics curve analysis was used to assess the discrimination ability of the score. The score was then validated and compared to the MR PREDICTS score.

Results

The derivation/validation included 270/116 patients, respectively. After multivariate logistic regression analysis, pre stroke mRS, age, admission glycaemia, admission NIHSS, collateral flow, Clot Burden Score, Alberta Stroke Program Early CT score were used to create a new prognostic scoring system called Tor Vergata Stroke Score (TVSS). TVSS revealed a good prognostic accuracy with an AUC of 0.825 [95% CI 0.77–0.88] in the derivation cohort and an AUC of 0.820 [95% CI 0.74–0.90] in the validation cohort. When compared to the MR PREDICTS in the validation cohort, TVSS demonstrated higher prediction ability which was, however, not statistically significant (0.80 vs 0.78; P = 0.26).

Conclusions

TVSS is a reliable tool for selection of AIS candidates for MT and optimization of transfer to comprehensive stroke centers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G et al (2012) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379:2352–2363. https://doi.org/10.1016/S0140-6736(12)60768-5 CrossRefPubMed Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G et al (2012) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379:2352–2363. https://​doi.​org/​10.​1016/​S0140-6736(12)60768-5 CrossRefPubMed
7.
Zurück zum Zitat Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 355:1670–1674CrossRef Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 355:1670–1674CrossRef
13.
Zurück zum Zitat Kim JJ, Fischbein NJ, Lu Y, Pham D, Dillon WP (2004) Regional angiographic grading system for collateral flow correlation with cerebral infarction in patients with middle cerebral artery occlusion. Stroke 35:1340–1344CrossRef Kim JJ, Fischbein NJ, Lu Y, Pham D, Dillon WP (2004) Regional angiographic grading system for collateral flow correlation with cerebral infarction in patients with middle cerebral artery occlusion. Stroke 35:1340–1344CrossRef
14.
Zurück zum Zitat Venema E, Mulder MJHL, Roozenbeek B, Broderick JP, Yeatts SD, Khatri P et al (2017) Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials. BMJ 357:1710. https://doi.org/10.1136/bmj.j1710 CrossRef Venema E, Mulder MJHL, Roozenbeek B, Broderick JP, Yeatts SD, Khatri P et al (2017) Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials. BMJ 357:1710. https://​doi.​org/​10.​1136/​bmj.​j1710 CrossRef
15.
Zurück zum Zitat Mittmann N, Seung SJ, Hill MD, Phillips SJ, Hachinski V, Coté R et al (2012) Impact of disability status on ischemic stroke costs in Canada in the first year. Can J Neurol Sci 39:793–800CrossRef Mittmann N, Seung SJ, Hill MD, Phillips SJ, Hachinski V, Coté R et al (2012) Impact of disability status on ischemic stroke costs in Canada in the first year. Can J Neurol Sci 39:793–800CrossRef
16.
17.
Zurück zum Zitat German Stroke Study Collaboration (2004) Predicting outcome after acute ischemic stroke: an external validation of prognostic models. Neurology 62:581–585CrossRef German Stroke Study Collaboration (2004) Predicting outcome after acute ischemic stroke: an external validation of prognostic models. Neurology 62:581–585CrossRef
25.
Zurück zum Zitat Rothwell PM, Treating individuals 2 (2005) Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365:176–186CrossRef Rothwell PM, Treating individuals 2 (2005) Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365:176–186CrossRef
Metadaten
Titel
Selection of anterior circulation acute stroke patients for mechanical thrombectomy
verfasst von
Fabrizio Sallustio
Nicola Toschi
Alfredo Paolo Mascolo
Federico Marrama
Daniele Morosetti
Valerio Da Ros
Roberto Gandini
Fana Alemseged
Giacomo Koch
Marina Diomedi
Publikationsdatum
03.07.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 11/2019
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09454-2

Weitere Artikel der Ausgabe 11/2019

Journal of Neurology 11/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.